S'abonner

Ziziphus spina-christi L. extract attenuates bleomycin-induced lung fibrosis in mice via regulating TGF-β1/SMAD pathway: LC-MS/MS Metabolic profiling, chemical composition, and histology studies - 16/06/24

Doi : 10.1016/j.biopha.2024.116823 
Sameh S. Elhady a, b, 1, Marwa S. Goda c, 1, Eman T. Mehanna d, Norhan M. El-Sayed e, Reem M. Hazem e, Mahmoud A. Elfaky f, g, Ahmad J. Almalki h, Malik Suliman Mohamed i, j, Reda F.A. Abdelhameed c, k,
a King Abdulaziz University Herbarium, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia 
b Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia 
c Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt 
d Department of Biochemistry, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt 
e Department of Pharmacology & Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt 
f Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia 
g Centre for Artificial Intelligence in Precision Medicines, King Abdulaziz University, Jeddah 21589, Saudi Arabia 
h Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia 
i Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia 
j Department of Pharmaceutics, Faculty of Pharmacy, Khartoum University, Khartoum 11111, Sudan 
k Department of Pharmacognosy, Faculty of Pharmacy, Galala University, New Galala 43713, Egypt 

Corresponding author at: Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal UniversityIsmailia41522Egypt

Abstract

Ancient Egyptians (including Bedouins and Nubians) have long utilized Ziziphus spina-christi (L.), a traditional Arabian medicinal herb, to alleviate swellings and inflammatory disorders. It is also mentioned in Christian and Muslim traditions. Ziziphus spina-christi L. (Family: Rhamnaceae) is a plentiful source of polyphenols, revealing free radical scavenging, antioxidant, metal chelating, cytotoxic, and anti-inflammatory activities. Herein, different classes of the existing bioactive metabolites in Z. spina-christi L. were detected using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the first time. The study also aimed to assess the anti-inflammatory and antifibrotic properties of Z. spina-christi L. extract against bleomycin-induced lung fibrosis in an experimental mouse model. 32 male Swiss Albino mice were assigned into 4 groups; the first and second were the normal control group and the bleomycin positive control (single 2.5 U/kg bleomycin intratracheal dose). The third and fourth groups received 100 and 200 mg/kg/day Z. spina-christi L. extract orally for 3 weeks, 2 weeks before bleomycin, and 1 week after. The bioactive metabolites in Z. spina-christi L. extract were identified as phenolic acids, catechins, flavonoids, chalcones, stilbenes, triterpenoid acids, saponins, and sterols. The contents of total phenolic compounds and flavonoids were found to be 196.62 mg GAE/gm and 33.29 mg QE/gm, respectively. In the experimental study, histopathological examination revealed that lung fibrosis was attenuated in both Z. spina-christi L.- treated groups. Z. spina-christi L. extract downregulated the expression of nuclear factor kappa B (NF-κB) p65 and decreased levels of the inflammatory markers tumor necrosis factor-alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1), and c-Jun N-terminal kinase (JNK) in lung tissue. Z. spina-christi L. also downregulated the expression of the fibrotic parameters collagen-1, alpha-smooth muscle actin (α-SMA), transforming growth factor-beta 1 (TGF-β1), matrix metalloproteinase-9 (MMP-9) and SMAD3, with upregulation of the antifibrotic SMAD7 in lung tissue. Overall, the present study suggests a potential protective effect of Z. spina-christi L. extract against bleomycin-induced lung fibrosis through regulation of the TGF-β1/SMAD pathway.

Le texte complet de cet article est disponible en PDF.

Graphical Abstract




Le texte complet de cet article est disponible en PDF.

Highlights

Metabolic profiling of Z. spina-Christi L. extract was performed by LC-MS/MS.
Z. spina-Christi L. crude extract protected against bleomycin-induced lung fibrosis in mice.
Z. spina-Christi L. exhibited anti-inflammatory effects through reducing NF-κB and TNF-α.
Z. spina-Christi L. downregulated the expression of fibrotic TGF-β1, MMP-9 and SMAD-3.

Le texte complet de cet article est disponible en PDF.

Abbreviations : ALK5, DMSO, DPPH, ECM, JNK, LC-MS/MS, MCP-1, MMP-9, MT, NF-κB, PDGF, SMAD, TGF-β1, TNF-α, α-SMA

Keywords : Ziziphus spina-christi L., LC-MS/MS, antioxidant, lung fibrosis, transforming growth factor-beta 1, SMAD pathway, public health, drug discovery


Plan


© 2024  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 176

Article 116823- juillet 2024 Retour au numéro
Article précédent Article précédent
  • Chemopreventive effects of atractylenolide-III on mammary tumorigenesis via activation of the Nrf2/ARE pathway through autophagic degradation of Keap1
  • Fangyi Long, Pinghan Wang, Yu Ma, Xudong Zhang, Ting Wang
| Article suivant Article suivant
  • Cardioprotective effect of Cinnamamide derivative compound 10 against myocardial ischemia-reperfusion through regulating cardiac autophagy via Sirt1
  • Wenhua Xue, Jingjing Liu, Xueli Xu, Chengxin Chen, Bo Wei, Yangchao Zhao

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.